Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Johnson and Johnson
Colorcon
McKinsey
Medtronic

Last Updated: June 26, 2022

- Profile


✉ Email this page to a colleague

« Back to Dashboard

Note on Biologic Patents

Matching patents to biologic drugs is far more complicated than for small-molecule drugs.

DrugPatentWatch employs three methods to identify biologic patents:

  1. Brand-side disclosures in response to biosimilar applications
  2. These patents were identified from disclosures by the brand-side company, in response to a potential biosimilar seeking to launch. They have a high certainty of blocking biosimilar entry. The expiration dates listed are not estimates — they're expiration dates as indicated by the brand-side company.

  3. General brand-side disclosures
  4. These patents were identified from searching drug labels and other general disclosures from the brand-side company. This list may exclude some of the patents which block biosimilar launch, and some of these patents listed may not actually block biosimilar launch. The expiration dates listed for these patents are estimates, based on the grant date of the patent.

  5. Patents from broad patent text search
  6. For completeness, these patents were identified by searching the patent literature for mentions of the branded or ingredient name of the drug. Some of these patents protect the original drug, whereas others may protect follow-on inventions or even inventions casually mentioning the drug. The expiration dates listed for these patents are estimates, based on the grant date of the patent.

1) High Certainty: US Patents for Derived from Brand-Side Litigation

These patents were obtained from brand-side disclosures in response to biosimilar applications
Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Patent Expiration
Abbvie Inc. HUMIRA adalimumab Injection 125057 04/28/2017 See Plans and Pricing 2027-04-04
Abbvie Inc. HUMIRA adalimumab Injection 125057 10/17/2016 See Plans and Pricing 2027-04-04
Abbvie Inc. HUMIRA adalimumab Injection 125057 04/28/2017 See Plans and Pricing 2028-10-06
Abbvie Inc. HUMIRA adalimumab Injection 125057 02/21/2008 See Plans and Pricing 2034-11-14
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Patent Expiration

2) High Certainty: US Patents for Derived from Company Disclosures

These patents were obtained from company disclosures
Applicant Tradename Biologic Ingredient Dosage Form BLA Patent No. Estimated Patent Expiration Source
Eli Lilly And Company HUMATROPE somatropin For Injection 019640 See Plans and Pricing 2041-03-07 Company disclosures
Eli Lilly And Company HUMATROPE somatropin For Injection 019640 See Plans and Pricing 2041-03-07 Company disclosures
Eli Lilly And Company HUMATROPE somatropin For Injection 019640 See Plans and Pricing 2013-03-15 Company disclosures
Novo Nordisk Inc. NOVOLIN R insulin human Injection 019938 See Plans and Pricing 2014-05-06 Company disclosures
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Patent No. >Estimated Patent Expiration >Source

3) Low Certainty: US Patents for Derived from Patent Text Search

These patents were obtained by searching patent claims

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Mallinckrodt
Merck
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.